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Zebrafish is increasingly used as an animal model to study the effects of environmental
nuclear receptors (NRs) ligands. As most of these compounds have only been tested on
human NRs, it is necessary to measure their effects on zebrafish NRs. Estrogen receptors
(ER) α and β and peroxysome proliferator activated receptor (PPAR) γ are main targets of
environmental disrupting compounds (EDCs). In humans there are two distinct nuclear
ERs (hERα and hERβ), whereas the zebrafish genome encodes three ERs, zfERα, zfERβ1,
and zfERβ2. Only one isoform of PPARγ is expressed in both humans and zebrafish. In
this review, we described reporter cell lines that we established to study the interaction of
EDCs with human and zebrafish ERs and PPARγ. Using these cell lines, we observed that
zfERs are thermo-sensitive while zfPPARγ is not. We also showed significant differences
in the ability of environmental and synthetic ligands to modulate activation of zfERs and
zfPPARγ in comparison to hERs and hPPARγ. Some environmental estrogens (bisphenol
A, mycoestrogens) which are hER panagonists displayed greater potency for zfERα
as compared to zfERβs. hERβ selective agonists (8βVE2, DPN, phytoestrogens) also
displayed zfERα selectivity. Among hERα selective synthetic agonists, 16α-LE2 was the
most zfERα selective compound. Almost all zfPPARγ environmental ligands (halogenated
bisphenol A derivatives, phthalates, perfluorinated compounds) displayed similar affinity
for human and zebrafish PPARγwhile pharmaceutical hPPARγ agonists like thiazolidones
are not recognized by zfPPARγ. Altogether, our studies show that all hERs and hPPARγ
ligands do not control in a similar manner the transcriptional activity of zfERs and zfPPARγ
and point out that care has to be taken in transposing the results obtained using the
zebrafish as a model for human physiopathology.
Keywords: estrogen receptor, peroxysome proliferator activated receptor γ, environmental disrupting compounds,
reporter cell lines, human, zebrafish
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Introduction
Human nuclear hormone receptors (NHRs) are a family of
48 transcription factors, many of which have been shown to
be activated by ligands. NHRs regulate cognate gene networks
involved in key physiological functions such as cell growth
and differentiation, development, homeostasis, or metabolism
(Gronemeyer et al., 2004; Germain et al., 2006). Consequently,
inappropriate exposure to environmental pollutants often leads
to proliferative, reproductive, and metabolic diseases, including
hormonal cancers, infertility, obesity or diabetes. NHRs are
modular proteins composed of several domains, most notably
an N-terminal domain, which harbors a ligand-independent
activation function (AF-1), a central DNA-binding domain
(DBD), and a C-terminal ligand-binding domain (LBD) hosting
a ligand-dependent transcriptional activation function (AF-2)
(Gronemeyer et al., 2004). In the absence of the cognate ligand,
some NHRs are located in the nucleus, bind to the DNA response
elements of their target genes, and recruit corepressors, while
others are located in the cytoplasm in an inactive complex with
chaperones.
Ligand binding induces major structural alterations of the
receptor LBDs, leading to (1) destabilization of corepressor
or chaperone interfaces, (2) exposure of nuclear localization
signals to allow nuclear translocation and DNA binding of
cytoplasmic receptors, and (3) recruitment of coactivators
triggering gene transcription through chromatin remodeling and
activation of the general transcription machinery. The crystal
structures of many NHR LBDs have been determined, revealing
a conserved core of 12 α-helices (H1–H12) and a short two-
stranded antiparallel β-sheet (S1 and S2) arranged into a three-
layered sandwich fold. This arrangement generates a mostly
hydrophobic cavity in the lower half of the domain, which
can accommodate the cognate ligand. In all hormone-bound
LBD structures, the ligand-binding pocket (LBP) is sealed by
helix H12. This conformation is specifically induced by the
binding of hormones or synthetic agonists and is referred to
as the “active conformation” because it allows the dissociation
of corepressors and favors the recruitment of transcriptional
coactivators (Bourguet et al., 2000; Renaud and Moras, 2000;
Pike, 2006).
In contrast to agonist binding, interaction with antagonists
prevents the correct positioning of helix H12, thus avoiding
association with the LxxLL motifs of coactivators. The LBD also
contributes to the modulation of the N-terminal AF-1 through
interdomain crosstalk so that both AF-1 and AF-2 domains can
recruit a range of coregulatory proteins and act individually or in
a synergistic manner (Benecke et al., 2000; Bommer et al., 2002;
Wilson, 2011).
Among nuclear receptors, ERs and PPARγ are main
targets of numerous synthetic substances released into the
environment by human activities. These substances can act as
endocrine-disrupting chemicals (EDCs) causing reproductive,
developmental, metabolic, or neurological diseases as well as
hormone-related cancers (Diamanti-Kandarakis et al., 2009).
Many EDCs are man-made compounds, for example bisphenols,
phthalates, parabens, dioxins, pesticides, alkylphenols,
organotins, polychlorinated biphenyls, or perfluoroalkyl
compounds. Some natural EDCs can also be found in plants
and fungi. Standard methods to study interaction of EDCs with
these nuclear receptors use stable cell reporter gene assays based
on human ERs and PPARγ activation (Balaguer et al., 1999;
Legler et al., 1999; Seimandi et al., 2005; Riu et al., 2011a). To
address whether chemicals exert an effect at the organismal level,
ER activity assays have been developed for zebrafish. In these
animals, GFP reporter constructs are designed to act in certain
tissues exclusively (such as liver or brain) (Kurauchi et al., 2005;
Brion et al., 2012) or in all tissues of embryos and larvae (Gorelick
and Halpern, 2011; Lee et al., 2012). Zebrafish has also been
used as an in vivo model to study the effect of environmental
compounds on PPARγ (Riu et al., 2014). Zebrafish stores neutral
lipid triglycerides in visceral, intramuscular, and subcutaneous
adipocyte depots (Tingaud-Sequeira et al., 2012). Studies of the
zebrafish embryo, which is optically transparent thus facilitating
the labeling and detection of lipid depots using lipid staining
(Minchin and Rawls, 2011), have shown that white adipose tissue
appearance is correlated with size rather than the age of the fish.
By using zebrafish as a PPARγ ligand screening model, we have
showed that halogenated-BPA analogs are potent inducers of
lipid accumulation in vivo through PPARγ signaling (Riu et al.,
2014).
In order to evaluate the effects of environmental and
pharmaceutical compounds on the transcriptional activity of
zfERs and zfPPARγ and to compare the data with their activity on
hERs and hPPARγ, we established human and zebrafish ERs and
PPARγ reporter cell lines in the same cellular context (Balaguer
et al., 1999; Seimandi et al., 2005; Pinto et al., 2014; Riu et al.,
2014). In HeLa cells stably expressing an ERE-driven luciferase
reporter (HELN cells), we expressed the full-length hERα, hERβ,
zfERα, zfERβ1, and zfERβ2, respectively. Similarly, in HeLa cells
stably expressing a GAL4RE-driven luciferase reporter (HG5LN
cells), we expressed a fusion protein consisting of the hPPARγ
or zfPPARγ ligand binding domain (LBD) and the DNA binding
domain (DBD) of the yeast transcription factor GAL4 (GAL4-
PPARγ).
The resulting HELN-ERs and HG5LN PPARγ cell lines were
used to evaluate the effects of environmental compounds on
gene transactivation by the five ERs and the two PPARγ, and to
compare these effects with results obtained on hER and PPARγ
orthologs. Since zebrafish is used as a model for studying the
effects of environmental compounds in vivo, determining the
transcriptional profiles of these compounds on the zfERs and
zfPPARγ is crucial to support the zebrafish model for ER- and
PPARγ-related studies and their extrapolation to the mammalian
system.
Estrogen Receptors
Estrogen signaling is mainly mediated by the two estrogen
receptors ERα (also called NR3A1) and ERβ (also called NR3A2)
(Jensen and Jordan, 2003; Dahlman-Wright et al., 2006) which
play important roles in the growth and maintenance of various
tissues such as the mammary gland, uterus, bones, or the
cardiovascular system. Like most NRs, ERs bind as dimers
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to DNA response elements in the promoter region of target
genes and respond to the naturally occurring sex hormone 17β-
estradiol (E2). Both hERs are widely distributed throughout the
body, displaying distinct but overlapping expression patterns
in a variety of tissues (Couse and Korach, 1999). hERα is
primarily expressed in the uterus, liver, kidney, and heart,
whereas hERβ is preferentially expressed in the ovary, prostate,
lung, gastrointestinal tract, bladder, and hematopoietic and
central nervous systems (Kuiper et al., 1997). However, hERα
and hERβ are coexpressed in a number of tissues including the
mammary gland, thyroid, adrenal, bones, and some regions of
the brain. Although hERα and hERβ share similar mechanisms
of action, several differences in the transcriptional abilities
of each receptor and distinct phenotypes between gene-null
animals have been identified, suggesting that these receptors may
regulate distinct cellular pathways (Curtis et al., 1996; Couse
and Korach, 1999). Interestingly, when hERs are coexpressed,
hERβ exhibits an inhibitory action on ERα-mediated gene
expression (Pettersson et al., 2000; Liu et al., 2002), so that
hERβ has been shown to antagonize several hERα-mediated
effects including fat reduction and cell proliferation in breast,
uterus, or prostate (Ogawa et al., 1998; Weihua et al., 2000;
Lindberg et al., 2003). Furthermore, in addition to controlling
the normal development and function of the reproductive system
and other tissues, estrogens are key regulators of primary breast
and prostatic cancer growth (Jensen and Jordan, 2003). Roughly
40% of human cancers require steroid hormones for their
growth and the first-line therapy for treatment of hormone-
dependent cancers is based on androgen and estrogen antagonists
interacting with AR or ERs and shutting down the corresponding
hormone-responsive pathway. Interestingly, ERβ has been shown
to antagonize ERα-mediated effects on cell proliferation in
the breast, uterus, ovary, and prostate (Weihua et al., 2000;
Lindberg et al., 2003; Ellem and Risbridger, 2009). In this
regard, estrogens with selectivity for either ER subtypes may
produce different biological outcomes, particularly on cancer
cell proliferation. Given the widespread role of ERs in human
physiology, it is not surprising that environmental compounds
which bind to ERs, thus substituting for the natural hormone and
deregulating the fine-tuned action of E2, can lead to ER-related
disorders including breast, endometrial, colorectal, or prostate
cancers, as well as neurodegenerative, inflammatory, immune,
cardiovascular, and metabolic diseases.
Small fish including zebrafish (Danio rerio) are increasingly
being used as model species to study in vivo effects of EDCs
(Segner, 2009; Vosges et al., 2010; Brion et al., 2012). In zebrafish,
three zfER subtypes (zfERα, zfERβ1, and zfERβ2) are present
(Menuet et al., 2002; Hawkins and Thomas, 2004). Zebrafish
ERα (esr1) is orthologous to the human ERα, while ERβ1
(esr2b) and ERβ2 (esr2a) are orthologs of the human ERβ
(Bardet et al., 2002). The overall amino-acid sequence identity
between the zfER subtypes and their corresponding human ER
orthologs is approximately 50% (Menuet et al., 2002). ZfERs are
differently expressed and regulated in reproductive tissue like
gonads, liver, as well as in brain. In adult liver, E2 induces zfERα
expression while it has no effect on zfERβ2 and represses zfERβ1
expression (Menuet et al., 2002). Moreover, both zfERα and
zfERβ2 upregulate zfERα expression after E2 exposure, whereas
zfERβ1 has no effect on this expression (Menuet et al., 2004).
These studies suggest that the different forms of zfERs have
partially distinct and nonredundant functions. Hence, in the
perspective of developing fish in vitro assays, it is essential to
take into account all zfER subtypes in the assessment of chemical
estrogenicity in zebrafish. Since these three zfERs are thought to
mediate different biological effects, there is an increased interest
in finding subtype-selective zfER ligands.
Estrogen Receptors Reporter Cell Lines
To understand and to evaluate impact of xenoestrogens on
ER-signaling pathway, it is necessary to develop cell-based
transcription assay systems that could reflect different cellular
contexts and/or different model species. In vitro assays based on
reporter gene driven by ERE have been proven to be useful and
relevant screening tools to address the large number of chemicals
yet needed to be tested for their estrogenic potential. We and
other groups have developed stable reporter gene assays based
on human ERα and ERβ activation in different cell contexts
and successfully used them to characterize estrogenic potency
of chemicals (Balaguer et al., 1999; Legler et al., 1999; Wilson
et al., 2004; Sotoca et al., 2008; Docquier et al., 2013). In order
to take into account the species of origin of studied receptor
in hazard assessment of estrogenic chemicals in fish, we have
developed in vitro stable reporter gene assays derived from fish
species (Molina-Molina et al., 2008; Cosnefroy et al., 2012; Pinto
et al., 2014). Among them, HELN-zfERα, -zfERβ1, and -zfERβ2
(Pinto et al., 2014) reporter cell lines were established in a similar
way than HELN-hERα and -hERβ cell lines (Pinto et al., 2014).
Briefly, HELN-ERs cell lines cells were obtained by transfection of
HELN cells (HeLa cells stably transfected with the ERE-βGlobin-
Luc-SVNeo plasmid) (Balaguer et al., 1999) by the corresponding
pSG5-puro plasmids (pSG5-hERα-puro, -hERβ-puro -zfERα-
puro, -zfERβ1-puro, and -zfERβ2-puro, respectively).
Selectivity of Chemicals for Human and
Zebrafish Estrogen Receptors
Screening of endogenous, environmental and synthetic ligands
in the HELN-zfER cell lines showed that known mammalian
ER ligands are also able to induce transcriptional activity
of zebrafish ER subtypes (Pinto et al., 2014). This screening
allowed us to assess differences in the potency of the estrogenic
compounds among the three zfER subtypes, and compare their
selectivity toward hERs using a similar human cellular context.
The HELN-zfERs cells were incubated at 28◦C after addition
of chemicals to the cells because it is a more physiologically
relevant temperature for zebrafish, which increased the potency
of estradiol approximately 10-fold compared to incubation at
37◦C. Temperature sensitivity of fish ERs has already been
reported using reporter gene assays (Matthews et al., 2002;
Cosnefroy et al., 2009) and the reason seems to be thermo-
dependence of estrogen binding (Tan et al., 1999; Matthews et al.,
2002; Sumida et al., 2003).
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We have shown that there are clear differences between the
selectivity of various (anti)estrogens for zebrafish and human
ER isoforms, establishing the fact that a direct translation of
(anti)estrogenic effects (activities or potencies) from mammals
to zebrafish is not possible. Although none of the tested
compounds specifically activated either zebrafish or human ERs,
transcriptional activities toward human and zebrafish ERs need
to be studied.
Natural (E2) and pharmaceutical (EE2) estrogens display
similar affinities for hERs and zfERs. Some environmental
estrogens (α-zearalanol, bisphenol-A) with similar affinity
for hERs preferentially activated zfERα rather than zfERβs.
Other environmental estrogens (nonylphenol mixture, 4-tert-
octylphenol) with similar affinity for hERs displayed slightly
higher affinity for zfERα and zfERβ2 than for zfERβ1.
Benzophenone 2 and phytoestrogens (genistein, liquiritigenin)
which have higher affinity for hERβ than for hERα also displayed
slightly higher affinity for zfERα and zfERβ2 than for zfERβ1.
Finally, hERβ selective synthetic compounds (8β-vE2, DPN)
preferentially activated zfERα compared to zfERβs. On the
contrary and similar to hERs, the synthetic compound 16α-E2,
which has 1000-fold more selectivity for hERα (Escande et al.,
2006), also exhibited higher affinity for zfERα compared to the
zfERβ subtypes and is the most selective compound for zfERα
nowadays (Figure 1; Table 1).
To gain structural insights into the zfERα selectivity of 16α-
LE2 in human and zebrafish ERs, we used the web-based
server EDMon (Endocrine Disruptor Monitoring; http://atome2.
cbs.cnrs.fr/AT2B/SERVER/EDMon.html) (Delfosse et al., 2012)
to model zfERs in complex with this ligand. The structural
FIGURE 1 | Transcriptional activity of hERα, hERβ, zfERα, zfERβ1, and
zfERβ2 in response to the synthetic pharmaceutical compound
16α-LE2. HELN-hERα (•), -hERβ1 (), -zfERα (©), HELN-zfERβ1 (),
HELN-zfERβ2 (♦) cells were exposed to different concentrations of 16α-LE2.
Results are expressed as % of 10 nM E2 treatment and are derived from
Escande et al. (2006) and Pinto et al. (2014).
TABLE 1 | 16αLE2 ERs EC50 and maximal activities.
NR EC50 (nM) Maximal activity (%)
hERα 0.093 ± 0.025 100
hERβ 92.9 ± 1.4 100
zfERα 0.79 ± 0.43 100
zfERβ1 240 ± 30.2 100
zfERβ2 74.6 ± 7.08 100
basis of the hERα and hERβ selectivity toward certain ligands
has been associated with two amino acid differences in their
ligand-binding pockets. Indeed, L384 and M421 of hERα are
replaced by M336 and I373 in hERβ, respectively (Figure 2
and Manas et al., 2004). Superimposition of the 16α-LE2-bound
zfERα model on the crystal structure of hERα in complex
with E2 (PDB code 3UUD) showed that the phenol ring of
16α-LE2 occupies the same position as that of E2 and is
engaged in a network of hydrogen bonds with E353 from
helix 3 (H3) and R394 from H5 (Figure 2A). On the other
side of the ligand-binding pocket (LBP), it appears that the
hydrogen bond observed between the 17-hydroxyl group of
E2 and H524 (H11) is conserved in 16α-LE2. The difference
FIGURE 2 | Modeling of the interaction between 16α-LE2 and the
human (h) and zebrafish (zf) estrogen receptors. Superposition of the
structures of hERα (A) and hERβ (B) LBDs bound to E2 (blue) on to the
molecular models of the 16α-LE2-bound zfERα (A) (green) and
16α-LE2-bound hERβ1 (red) and 16α-LE2-bound hERβ2 (yellow) (B) LBDs. In
zfERα, the lactone ring of 16α-LE2 points toward M421 (H7) which undergoes
a large conformational change (black arrow) to accommodate this additional
group. In hERβ, the linear M421 present in ERα (M389 in zfERα) is replaced by
branched residues (I373 in hERβ, I406 in zfERβ1 and L391 in zfERβ2), which
are characterized by a much smaller intrinsic flexibility that maintains the
synthetic ligand in a position where it interacts unfavorably with M336 in hERβ,
L369 in zfERβ1 and L354 in zfERβ2. This figure is derived from Pinto et al.
(2014).
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between the two complexes resides in the lactone ring of 16α-
LE2 which points toward M421 (H7) that must undergo a large
conformational change to accommodate this additional group.
In hERβ, the linear M421 is replaced by the branched residue
Ileu 373 characterized by a much smaller intrinsic flexibility
(Figure 2B). As a consequence, I373 maintains the synthetic
ligand in a position where it interacts unfavorably with M336
(H3). Therefore, 16α-LE2 adopts different positions in hERα
and hERβ, the more constrained environment provided by the
latter accounting for the weaker affinity of the ligand for this
receptor subtype. The affinity values measured with the zebrafish
receptors reflect the variations in the space constraints provided
by the different combinations of residues in the three receptor
subtypes. With H3 and H7 residues identical to those of the
human receptor, zfERα interacts with 16α-LE2 with the highest
affinity. The slight difference in the binding affinity of 16α-LE2
for hERα and zfERα relies most likely on the replacement of L349
(H3) by a methionine residue (M317) (Figure 2A) and a possible
loss of a favorable interaction provided by the branched but not
by the linear residue (Figure 2A). With a conserved isoleucine in
H7 (I406) and a leucine residue in H3 (L369) (Figure 2B), zfERβ1
displays the most constrained LBP reflecting the weakest binding
affinity for 16α-LE2. This receptor combines two large residues
with low (isoleucine) and medium (leucine) flexibilities. The
replacement of I406 in H7 of zfERβ1 by a leucine residue (L391)
(Figure 2B) in zfERβ2 provides a slight gain in LBP plasticity,
in agreement with the slightly better affinity of 16α-LE2 for the
latter.
The inability of hERβ-selective phytoestrogens (genistein and
liquiritigenin) and pharmaceuticals (8bv-E2, DPN) to activate
preferentially the zfERβ isoforms is explained by the mutation
of a critical amino acid involved in genistein binding in hERβ. In
all zfERs, the position homologous to hERβ M336 is occupied,
as in hERα, by a leucine residue (Figure 2) (Sassi-Messai et al.,
2009). This amino acid change most likely accounts for the lack
of obvious selectivity of the phytoestrogens toward the zfERβ
subtypes.
FIGURE 3 | Transcriptional activity of hPPARγ in response to the
synthetic pharmaceutical compound rosiglitazone and the
environmental compounds TBBPA, MEHP, and PFOA. HG5LN hPPARγ
and zfPPARγ cells were exposed to different concentrations of rosiglitazone
(•), TBBPA (), MEHP (©), and PFOA (♦). Results are expressed as % of
basal activity and are derived from Riu et al. (2011a).
Peroxysome Proliferator γ
PPARs are involved in the regulation of glucose, lipid, and
cholesterol metabolism in response to fatty acids and their
derivatives, eicosanoids, and drugs used in the treatment of
hyperlipidemia and diabetes. The human PPAR subfamily
contains three members known as hPPARα, hPPARβ,
and hPPARγ. Each hPPAR subtype shows a distinct tissue
distribution and ligand preference. hPPARγ is highly expressed
in adipose tissue and is a central regulator of lipid storage
and adipocyte gene expression and differentiation (Tontonoz
et al., 1995) and is involved in various pathophysiological
disorders, including metabolic disease, insulin resistance, and
diabetes (Rosen and Spiegelman, 2001). hPPARγ is the target
for antidiabetic agents of the thiazolidinedione class, which
includes troglitazone, pioglitazone, and rosiglitazone. The LBD
of hPPARγ is rather large and the diversity of ligands that can
be accommodated within its pocket, mainly represented by
lipid derivatives, may contribute to the large array of roles that
have been assigned to hPPARγ. Given the physiological role of
hPPARγ in adipose tissue development and maintenance, it has
been proposed that disruption of regulation pathways under
the control of hPPARγ may be involved in the onset of diabetes
and obesity (Swedenborg et al., 2009). Indeed, activation of this
receptor by certain xenobiotic compounds has been shown to
stimulate adipogenesis in vitro and in vivo through induction
FIGURE 4 | Transcriptional activity of zfPPARγ in response to the
synthetic pharmaceutical compound rosiglitazone and the
environmental compounds TBBPA, MEHP, and PFOA. HG5LN hPPARγ
and zfPPARγ cells were exposed to different concentrations of rosiglitazone
(•), TBBPA (), MEHP (©), and PFOA (♦). Results are expressed as % of
basal activity and are derived from Riu et al. (2011a) and Riu et al. (2014).
TABLE 2 | EC50 and maximal activities of PPARγ ligands.
hPPARγ zfPPARγ
Ligand EC50 (µM) (maximal E50 (µM) (maximal
activity %) activity %)
Rosiglitazone 0.027 ± 0.003 (100) ND (27.9)
TBBPA 0.762 ± 0.136 (42,4) 1.45 ± 0.33 (40)
MEHP 1050 ± 73 (57) 11.3 ± 1.29 (100)
PFOA 380 ± 71 (37.8) ND (24.2)
ND, Not determined.
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of the differentiation of preadipocytes of the fibroblastic lineage
into mature adipocytes (Grun and Blumberg, 2009; le Maire
et al., 2009; Janesick and Blumberg, 2011; Riu et al., 2011a). This
has led to the “obesogen hypothesis,” according to which, in
addition to disruption of the balance between caloric intake and
expenditure characterizingmodern life-style, the rapidly growing
obesity epidemic could also implicate environmental risk factors
including an increased exposure to chemicals that interfere with
any aspects of metabolism (Grun and Blumberg, 2009; Janesick
and Blumberg, 2011, 2012). Accordingly, compounds that have
the potential to disrupt any metabolic signaling pathways and
lead to increased fat accumulation and obesity are referred to as
“obesogens” (Grun and Blumberg, 2006).
Like for ERs, zebrafish begin to be used as model species to
study in vivo effects of EDCs on PPARγ (Lyche et al., 2011; Riu
et al., 2014). Similar to mammals, zebrafish store neutral lipid
triglycerides in the visceral, intramuscular, and subcutaneous
adipocyte depots. The first adipocytes, which can be observed
from day 8 to 12, or at a minimal size of about 5mm (Imrie
and Sadler, 2010), appear in the pancreatic region, then in the
viscera, and later on, in the subcutaneous and cranial regions
(Flynn et al., 2009; Imrie and Sadler, 2010). Lipid staining can be
detected before this stage; however, at this time point, the lipids
are not stored in adipocytes, but rather in the yolk, hepatocytes,
blood vessels, skeletal myocytes, jaw chondrocytes, and neuronal
tissue in the brain (Imrie and Sadler, 2010).
Pparγ reporter cell lines
HG5LN-hPPARγ and -zfPPARγ reporter cell lines were
established in a similar way (Seimandi et al., 2005; Riu et al.,
2014). Briefly, HG5LN-PPARγ cell line was obtained by
transfection of HG5LN cells (HeLa cells stably transfected
with the GALRE5-βGlobin-Luc-SVNeo plasmid) (Seimandi
et al., 2005) by the corresponding pSG5-puro plasmids [pSG5-
GAL4(DBD)-hPPARγ(LBD)-puro and -zfPPARγ(LBD)-puro,
respectively]. Interestingly, the thermodependence observed for
zfERs is not shared by zfPPARγ (Riu et al., 2014).
Selectivity of chemicals for human and
zebrafish PPARγ
Screening of environmental and pharmaceutical ligands in the
HG5LN-zfPPARγ cell lines showed that known hPPARγ ligands
are not always able to induce transcriptional activity of zebrafish
FIGURE 5 | (A) Sequence alignment of human, mouse, and zebrafish
PPARγ ligand binding pocket residues. Asterisks denote residues in
contact with TBBPA and/or rosiglitazone (PDB code 2PRG). Interacting
residues that differ between sequences are highlighted in red. (B) TBBPA
(carbon atoms colored in green) and rosiglitazone (magenta, PDB code
2PRG) as they are positioned in the human PPARγ. Residues that differ in the
ligand binding pocket of human and zebrafish PPARγ are displayed as green
and blue sticks, respectively. The human PPARγ Gly284 and Cys285 which
are replaced by serine and tyrosine residues in zebrafish PPARγ are indicated
in red. This figure is derived from Riu et al. (2011a).
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PPARγ (Riu et al., 2011a). Pharmaceutical hPPARγ ligands
like thiazolidones (rosiglitazone, troglitazone) do not or very
weakly bind to zfPPARγ. On the contrary, environmental PPARγ
compounds including phthalates (MEHP), perfluorinated
compounds (PFOA, PFOS) and halogenated derivatives of
BPA (TBBPA, TCBPA) are common activators of hPPARγ and
zfPPARγ (Figures 3, 4; Table 2). We also provide evidence that
activation of ERs and PPARγ depends on the halogenation
degree of BPA analogs. The bulkier are brominated BPA analogs,
the greater is their capability to activate PPARγ and the weaker
is their estrogenic potential (Riu et al., 2011b).
Comparison of human and zebrafish PPARγ sequences
reveals several residue differences which could explain the
differential ligand specificity of the various species (Figure 5A).
In particular, the replacement of human PPARγ Gly284
and Cys285 by serine and tyrosine residues in zebrafish
PPARγ provides a rationale for the weak binding affinity
of rosiglitazone for this receptor as compared to that
observed for the human homolog (Figure 4B). In contrast,
the different binding mode of halogenated compounds allows
both hPPARγ and zfPPARγ to accommodate TBBPA and TCBPA
(Figure 5B).
Structural and biophysical studies revealed that TBT binds to
both hRXR and hPPARγ through formation of a covalent bond
between the tin atom and the sulfur atom of cysteine residues
located in the LBP of both receptors (le Maire et al., 2009;
Delfosse et al., 2014). In RXR, this cysteine (Cys432) is located
in helix H11 and is conserved in several species. In contrast, the
cysteine residue of PPARγ (Cys285) resides in H3 and is not
conserved in several species including zebrafish.
Conclusion
We have shown above that there are clear differences between
the activity of various EDCs for zebrafish and human ERs
and PPARs, demonstrating that a direct translation of effects
from mammals to zebrafish is not possible. The differences
revealed in this study, in terms of transcriptional activities
toward human and zebrafish ERs and PPARs, highlight the need
to take into account the species of origin when assessing the
potency of chemicals. This is particularly important with regard
to EDCs screening for hazard assessment since at the present
time established test guidelines are only based on human cell lines
expressing human nuclear receptors.
To this end, such in vitro cell lines expressing zebrafish nuclear
receptors can serve as useful screening tools to address nuclear
receptor potency of chemicals for fish models. Hence, an initial
screening should be followed up with an NR-subtype specific
analysis using both human and zebrafish NRs to elucidate the full
spectrum of NR-mediated EDCs effects.
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